Clinical Trial Update: Study Of Perennial Allergic Rhinitis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for perennial allergic rhinitis sponsored by GlaxoSmithKline has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Snippet

Sponsor: GlaxoSmithKline | Conditions: Rhinitis, Allergic, Seasonal | Phase 3 | Status: COMPLETED